Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Receives $44 90 Average Price Target from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) traded down 3.8% during trading on Wednesday following insider selling activity. The company traded as low as $32.76 and last traded at $33.04. 482,383 shares were traded during trading, a decline of 37% from the average session volume of 770,039 shares. The stock had previously […]
Crinetics Pharmaceuticals (NASDAQ:CRNX) Shares Gap Up on Analyst Upgrade themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price objective boosted by Evercore ISI from $41.00 to $48.00 in a research note published on Monday morning, MarketBeat Ratings reports. They currently have an outperform rating on the stock. CRNX has been the topic of a number of other research reports. Cantor Fitzgerald reaffirmed an overweight […]
HC Wainwright reiterated their buy rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research report report published on Monday, Benzinga reports. The firm currently has a $33.00 price target on the stock. Other equities analysts have also recently issued research reports about the stock. JMP Securities cut their price objective on […]